<unk>  is a bisphosphonate that is FDA approved for the treatment of hypercalcemia of malignancy,  multiple myeloma,  bone metastases of solid tumors,  osteoporosis,paget's disease,  postmenopausal osteoporosis.   Common adverse reactions include nausea,  fatigue, anemia,  bone pain,  constipation,  fever,  vomiting,  dyspnea.
Zoledronate
Risedronate
Etidronate
Ibandronate 
Zoledronic acid
Tiludronate
Alendronate
Denosumab